
What We're Reading: White Working Class Crisis; Duchenne Drug Price; Video Help for Caregivers
Less-Educated Whites Dying Younger
A new paper found that middle-aged white Americans with a high school degree or less are dying younger than others in their age group.
Monitoring Pricing for the New Duchenne Drug
After PTC Therapeutics bought Emflaza, a recently approved drug to treat Duchenne muscular dystrophy, the company said it would reexamine the price. Before the company has had a chance to release the new price, Senator Bernie Sanders (I-Vermont) and Representative Elijah Cummings (D-Maryland) are requesting information on how PTC plans to price the drug,
Instructional Videos to Help Caregivers
Figuring out how to manage medication, give injections, clean catheters, and more can be difficult for family caregivers. However, help is on the way. A new consortium of 15 organizations will provide training and instructional materials for family caregivers,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.